A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin
2017 ◽
Vol 235
◽
pp. 49-55
◽
2017 ◽
Vol 69
(11)
◽
pp. 1281
2013 ◽
Vol 9
(4)
◽
pp. 375-378
◽